Centre Hospitalier Intercommunal de Creteil

Créteil, Île-de-France Region 94010

0 studies enrolling now · 3 studies all time

What they study most

ALK+ Advanced NSCLC, ALK-positive Advanced NSCLC, Advanced Malignancies, Carcinoma, Lung Cancer, Non-small Cell Lung Cancer

Studies at this site

• A Study of Brigatinib Compared to Alectinib in Adults With Non-Small-Cell Lung Cancer — Completed
• A Study of Brigatinib in Participants With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non-Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or Ceritinib — Completed
• ALTA-1L Study: A Study of Brigatinib Versus Crizotinib in Anaplastic Lymphoma Kinase Positive (ALK+) Advanced Non-small Cell Lung Cancer (NSCLC) Participants — Completed